A3P Biomedical AB: Fast track publication of the STHLM3 MRI trial in The Lancet Oncology ...Middle East

STOCKHOLM, Aug. 13, 2021 /PRNewswire/ -- A3P Biomedical AB today announced that the publication of the STHLM3 MRI trial including 12,750 men has been fast tracked and is now published in the renowned peer-reviewed scientific publication The Lancet Oncology1. Results from the STHLM3 MRI...

Hence then, the article about a3p biomedical ab fast track publication of the sthlm3 mri trial in the lancet oncology was published today ( Friday 13/08/2021 - 07:46 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( A3P Biomedical AB: Fast track publication of the STHLM3 MRI trial in The Lancet Oncology )

Also on site :

• Meta Prepares 8,000 Layoffs to Offset AI Infrastructure Investments .. PYMNTS.com
• China’s DeepSeek unveils latest model a year after upending global tech
• Ella Langley Is Hosting 'Dinner at the Opry' — Here's How You Can Grab a Seat